Between 2005 and 2013, according to an investigation, the U.S. Federal Drug Administration (FDA) received a minimum of 30 complaints of compulsive gambling and 24 of other compulsive behavior such as hypersexuality and compulsive shopping that possibly stemmed from the use of Abilify.
No mention of adverse effects was listed in the U.S. patient medication guide that accompanies all drugs.
Additionally, online marketing of the drug continued without any warnings added to the drug’s description on the company’s websites.
Ver también:
Entradas
No hay comentarios:
Publicar un comentario